Impaired glucagon suppression accompanied by liver fat accumulation mediated worse blood glucose control in T2D patients.

Shuang Li, Jingfei Liu, Chun Yang, Yanjun Jin, Yiwen Zhou, Hang Zhao, Zhangyao Su, Yu Fu, Mei Zhang, XianYong Yin, Tao Yang, Yong Gu, Yang Chen
{"title":"Impaired glucagon suppression accompanied by liver fat accumulation mediated worse blood glucose control in T2D patients.","authors":"Shuang Li, Jingfei Liu, Chun Yang, Yanjun Jin, Yiwen Zhou, Hang Zhao, Zhangyao Su, Yu Fu, Mei Zhang, XianYong Yin, Tao Yang, Yong Gu, Yang Chen","doi":"10.1210/clinem/dgaf303","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease is prevalent in type 2 diabetes (T2D) and exacerbates hyperglycemia, but its impact on postprandial glucagon suppression remains unclear.</p><p><strong>Objective: </strong>To investigate the association between hepatic steatosis and impaired glucagon suppression during oral glucose tolerance tests (OGTT), and to evaluate the mediating role of glucagon dysregulation in linking liver fat to glycemic control.</p><p><strong>Design and methods: </strong>In this cross-sectional study, 604 patients with T2D underwent liver fat quantification via FibroScan Pro®-controlled attenuation parameter (CAP) and liver ultrasound. Postprandial glucagon suppression was assessed during 180-minute OGTT (0-, 30-, 60-, 120-, 180-min), with continuous glucose monitoring (CGM) in 287 participants. Glucagon suppression was calculated for early (0-30 min), late (30-180 min), and overall (0-180 min) phases. Multivariable regression and mediation analyses tested associations between CAP, glucagon dynamics, and CGM-derived glycemic profiles.</p><p><strong>Results: </strong>T2D patients with MASLD (CAP ≥238 dB/m, n=414) exhibited significantly impaired glucagon suppression compared to non-MASLD controls (n=190) across all phases (all P<0.05). Each 1-SD CAP increase independently predicted attenuated dose-dependent suppression in all phases (standardized β=0.183-0.303, P<0.001). Males showed greater suppression impairment than females and stronger CAP-associated dysregulation. Mediation analysis revealed that glucagon suppression mediated 14.9-33.9% of the adverse effects of liver fat on hyperglycemia.</p><p><strong>Conclusion: </strong>Liver fat accumulation in T2D is strongly associated with defective postprandial glucagon suppression, particularly in males, which mediates nearly one-third of its detrimental impact on glycemic control. Targeting hepatic steatosis and glucagon signaling may offer novel therapeutic strategies for T2D management.</p>","PeriodicalId":520805,"journal":{"name":"The Journal of clinical endocrinology and metabolism","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of clinical endocrinology and metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/clinem/dgaf303","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Metabolic dysfunction-associated steatotic liver disease is prevalent in type 2 diabetes (T2D) and exacerbates hyperglycemia, but its impact on postprandial glucagon suppression remains unclear.

Objective: To investigate the association between hepatic steatosis and impaired glucagon suppression during oral glucose tolerance tests (OGTT), and to evaluate the mediating role of glucagon dysregulation in linking liver fat to glycemic control.

Design and methods: In this cross-sectional study, 604 patients with T2D underwent liver fat quantification via FibroScan Pro®-controlled attenuation parameter (CAP) and liver ultrasound. Postprandial glucagon suppression was assessed during 180-minute OGTT (0-, 30-, 60-, 120-, 180-min), with continuous glucose monitoring (CGM) in 287 participants. Glucagon suppression was calculated for early (0-30 min), late (30-180 min), and overall (0-180 min) phases. Multivariable regression and mediation analyses tested associations between CAP, glucagon dynamics, and CGM-derived glycemic profiles.

Results: T2D patients with MASLD (CAP ≥238 dB/m, n=414) exhibited significantly impaired glucagon suppression compared to non-MASLD controls (n=190) across all phases (all P<0.05). Each 1-SD CAP increase independently predicted attenuated dose-dependent suppression in all phases (standardized β=0.183-0.303, P<0.001). Males showed greater suppression impairment than females and stronger CAP-associated dysregulation. Mediation analysis revealed that glucagon suppression mediated 14.9-33.9% of the adverse effects of liver fat on hyperglycemia.

Conclusion: Liver fat accumulation in T2D is strongly associated with defective postprandial glucagon suppression, particularly in males, which mediates nearly one-third of its detrimental impact on glycemic control. Targeting hepatic steatosis and glucagon signaling may offer novel therapeutic strategies for T2D management.

t2dm患者胰高血糖素抑制受损伴肝脂肪堆积介导血糖控制恶化。
背景:代谢功能障碍相关的脂肪变性肝病在2型糖尿病(T2D)中普遍存在并加剧高血糖,但其对餐后胰高血糖素抑制的影响尚不清楚。目的:探讨肝脂肪变性与口服糖耐量试验(OGTT)中胰高血糖素抑制受损的关系,并探讨胰高血糖素调节异常在肝脂肪与血糖控制之间的中介作用。设计和方法:在本横断面研究中,604例T2D患者通过FibroScan Pro®控制衰减参数(CAP)和肝脏超声进行肝脏脂肪定量。在180分钟OGTT(0、30、60、120、180分钟)期间,对287名参与者进行持续血糖监测(CGM),评估餐后胰高血糖素抑制。计算早期(0-30 min)、晚期(30-180 min)和整体(0-180 min)胰高血糖素抑制。多变量回归和中介分析测试了CAP、胰高血糖素动力学和cgm衍生的血糖谱之间的关联。结果:与非MASLD对照组(n=190)相比,T2D合并MASLD患者(CAP≥238 dB/m, n=414)在所有阶段均表现出胰高血糖素抑制显著受损(所有p)。结论:T2D患者肝脏脂肪堆积与餐后胰高血糖素抑制缺陷密切相关,尤其是在男性中,这介导了近三分之一的有害血糖控制影响。靶向肝脂肪变性和胰高血糖素信号可能为T2D治疗提供新的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信